NanoMR has secured $13 million in a Series B financing round led by Excel Venture Management. The startup, which is working on a device that can detect blood bacteria faster than traditional tests, will use the funds to advance the creation of instruments tailored to the clinical microbiology sector, said CEO Victor Esch.

Related Summaries